Search | Page 21 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... Associated Drug(s):  Azacitidine Phase:  ... dose (MTD) from Phase I. Other Names: Azacitidine 5-aza Vidaza 5-AZC AZA-CR ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  2. MDS - Treatment (OLD)

    ... to specifically treat MDS in the U.S. These include azacitidine (Vidaza®) and decitabine (Dacogen®), both considered ...

    Topic section last updated 03/10/2016 - 11:01pm.

  3. Clinical Trials Report for January 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 12/30/2014 - 10:45am.

  4. Clinical Trials Report for March 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of this ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 03/02/2015 - 10:06am.

  5. Clinical Trials Report for December 2014

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 11/25/2014 - 3:33pm.

  6. Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant (ICT-HCT)

    ... Associated Drug(s):  Azacitidine Decitabine ... Intervention:  Drug: Azacitidine Given IV or SC Other Names: 5 ...

    Clinical Trial last updated 04/27/2016 - 9:41am.

  7. Evaluation of RUX and AZA Combination as a Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm

    ... Associated Drug(s):  Azacitidine Phase:  ... 1, 2 and 3. Other Names: Jakafi INCB018424 INC424 Drug: Azacitidine (AZA) Four weeks (28 days) on therapy is considered one standard ...

    Clinical Trial last updated 04/28/2016 - 1:56pm.

  8. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    ... Associated Drug(s):  Azacitidine Phase:  ... Intervention:  Drug: 5-azacitidine and sargramostim 5-azacitidine will be administered days 1-5 of a ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  9. A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

    ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/27/2016 - 9:37am.

  10. Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS (UPCI 13-165)

    ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/29/2016 - 10:26am.